128 related articles for article (PubMed ID: 38350368)
1. Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy.
Feng Y; An Q; Zhao Z; Wu M; Yang C; Liang W; Xu X; Jiang T; Zhang G
Biomed Pharmacother; 2024 Mar; 172():116266. PubMed ID: 38350368
[TBL] [Abstract][Full Text] [Related]
2. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
3. β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling.
Cheng G; Li L; Li Q; Lian S; Chu H; Ding Y; Li C; Leng Y
Am J Cancer Res; 2022; 12(4):1535-1555. PubMed ID: 35530288
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.
Zhai B; Zhang N; Han X; Li Q; Zhang M; Chen X; Li G; Zhang R; Chen P; Wang W; Li C; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Biomed Pharmacother; 2019 Jun; 114():108812. PubMed ID: 30965237
[TBL] [Abstract][Full Text] [Related]
5. β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest.
Zhang R; Pan T; Xiang Y; Zhang M; Feng J; Liu S; Duan T; Chen P; Zhai B; Chen X; Wang W; Chen B; Han X; Chen L; Yan L; Jin T; Liu Y; Li G; Huang X; Zhang W; Sun Y; Li Q; Zhang Q; Zhuo L; Xie T; Wu Q; Sui X
Front Bioeng Biotechnol; 2020; 8():378. PubMed ID: 32457882
[TBL] [Abstract][Full Text] [Related]
6. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification.
Bai Z; Yao C; Zhu J; Xie Y; Ye XY; Bai R; Xie T
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801899
[TBL] [Abstract][Full Text] [Related]
8. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways.
Zhan YH; Liu J; Qu XJ; Hou KZ; Wang KF; Liu YP; Wu B
Asian Pac J Cancer Prev; 2012; 13(6):2739-44. PubMed ID: 22938451
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
10. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
Li G; Xie B; Li X; Chen Y; Xu Y; Xu-Welliver M; Zou L
Oncol Rep; 2015 Mar; 33(3):1427-33. PubMed ID: 25607351
[TBL] [Abstract][Full Text] [Related]
12. Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway.
Xiaomeng F; Lei L; Jinghong A; Juan J; Qi Y; Dandan Y
Braz J Med Biol Res; 2020; 53(6):e8885. PubMed ID: 32401925
[TBL] [Abstract][Full Text] [Related]
13. 2,2'-((1R,3R,4S)-4-methyl-4-vinylcyclohexane-1,3-diyl) bis(prop-2-en-1-amine), a bisamino derivative of β-Elemene, inhibits glioblastoma growth through downregulation of YAP signaling.
Cao LY; Xu JY; Zhuo XT; Zhang W; Wei LJ; Dong JH; Bai RR; Wang X; Jiang YY; Wang YJ; Ye XY; Xie T; Huang ZH
Am J Cancer Res; 2022; 12(12):5484-5499. PubMed ID: 36628286
[TBL] [Abstract][Full Text] [Related]
14. β-elemene alleviates esophageal fibrosis after endoscopic submucosal dissection via the FAP-mediated PTEN-PI3K/AKT signaling pathway.
Wu J; Hong C; Qiu T; Hu W; Chen J; Fang T
Heliyon; 2024 May; 10(10):e31537. PubMed ID: 38807882
[TBL] [Abstract][Full Text] [Related]
15. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT.
Liang Y; Li S; Zheng G; Zhang L
Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989
[TBL] [Abstract][Full Text] [Related]
16. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
17. β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.
Yang D; Xu X; Wang X; Feng W; Shen X; Zhang J; Liu H; Xie C; Wu Q; Miao X; Guo Y; Cai H; Wu L; Zhou S; Yao X; Wang Y; Xie T; Huang Z
Am J Cancer Res; 2021; 11(2):370-388. PubMed ID: 33575077
[TBL] [Abstract][Full Text] [Related]
18. β-elemene inhibits non-small cell lung cancer cell migration and invasion by inactivating the FAK-Src pathway.
Zhang H; Li S; Bao J; Ge N; Hong F; Qian L
Exp Ther Med; 2021 Oct; 22(4):1095. PubMed ID: 34504549
[TBL] [Abstract][Full Text] [Related]
19. β-elemene enhances cisplatin sensitivity of non-small cell lung cancer cells via the miR-17-5p/STAT3 axis.
Qian T; Wenxian T; Anbing H
Chem Biol Drug Des; 2024 Jan; 103(1):e14395. PubMed ID: 37973414
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
